Bright Minds Biosciences Inc (DRUG)
Cost of Revenue
$19.97K
Quarterly · Period ending: · CAD
DRUG Cost of Revenue
Latest reported$19.97K CADperiod ending
Latest reported$19.97K CADperiod ending
DRUG Quarterly Cost of Revenue · CAD ($0.00 → $19.97K)
Quarterly cost of revenue
High-resolution chart · PNG
DRUG cost of revenue history
Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (CAD) |
|---|---|
| 19,973 | |
| 20,130 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |